Molecular characterization and survival analysis of a cohort of glioblastoma, IDH-wildtype
Pathology - Research and Practice · 2024
DOI: 10.1016/j.prp.2024.155272 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathology - Research and Practice, 2024. Verfasst von Bilge Dundar und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Mayo Clinic, Rochester, MN, USA. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms, Isocitrate Dehydrogenase. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 16 Literaturangaben.
Abstract (Originalsprache)
Glioblastoma, IDH-wild type, the most common malignant primary central nervous system tumor, represents a formidable challenge in clinical management due to its poor prognosis and limited therapeutic responses. With an evolving understanding of its underlying biology, there is an urgent need to identify prognostic molecular groups that can be subject to targeted therapy. This study established a cohort of 124 sequential glioblastomas from a tertiary hospital and aimed to find correlations between molecular features and survival outcomes. Comprehensive molecular characterization of the cohort revealed prevalent alterations as previously described, such as TERT promoter mutations and involvement of the PI3K-Akt-mTOR, CK4/6-CDKN2A/B-RB1, and p14ARF-MDM2-MDM4-p53 pathways. MGMT promoter methylation is a significant predictor of improved overall survival, aligned with previous data. Conversely, age showed a marginal association with higher mortality. Multivariate analysis to account for the effect of MGMT promoter methylation and age showed that, in contrast to other published series, this cohort demonstrated improved survival for tumors harboring PTEN mutations, and that there was no observed difference for most other molecular alterations, including EGFR amplification, RB1 loss, or the coexistence of EGFR amplification and deletion/exon skipping (EGFRvIII). Despite limitations in sample size, this study contributes data to the molecular landscape of glioblastomas, prompting further investigations to examine these findings more closely in larger cohorts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Mayo Clinic, Rochester, MN, USA.
- Department of Pathology, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.
- Department of Pathology, University of Michigan, Ann Arbor, MI, USA.
- H. Lee Moffitt Cancer Center, Tampa, FL, USA.
- Department of Pathology, University of Iowa Hospitals and Clinics, Iowa City, IA, USA. Electronic address: osorio-lopesabathneto@uiowa.edu.
Zitieren
APA
Dundar, B., Alsawas, M., Masaadeh, A., Conway, K., Snow, A. N., Sompallae, R. R., Bossler, A. D., Ma, D., & Lopes Abath Neto, O. (2024). Molecular characterization and survival analysis of a cohort of glioblastoma, IDH-wildtype. Pathology - Research and Practice. https://doi.org/10.1016/j.prp.2024.155272
Vancouver
Dundar B, Alsawas M, Masaadeh A, Conway K, Snow AN, Sompallae RR, et al. Molecular characterization and survival analysis of a cohort of glioblastoma, IDH-wildtype. Pathology - Research and Practice. 2024. doi:10.1016/j.prp.2024.155272
BibTeX
@article{Dundar2024,
author = {Dundar, Bilge and Alsawas, Mouaz and Masaadeh, Amr and Conway, Kyle and Snow, Anthony N and Sompallae, Ramakrishna R and Bossler, Aaron D and Ma, Deqin and Lopes Abath Neto, Osorio},
title = {Molecular characterization and survival analysis of a cohort of glioblastoma, IDH-wildtype},
journal = {Pathology - Research and Practice},
year = {2024},
doi = {10.1016/j.prp.2024.155272}
}
EUVIMED